catechin has been researched along with Cachexia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Iloki-Assanga, S; Lujany, LML; McCarty, MF | 1 |
Argilés, JM; Barberis, P; Busquets, S; Figueras, M; Fontes de Oliveira, C; López-Soriano, FJ; Olivan, M; Sette, A; Toledo, M; Ventura da Silva, P | 1 |
Chan, YL; Lai, YJ; Li, TL; Wang, H; Wu, CJ | 1 |
3 other study(ies) available for catechin and Cachexia
Article | Year |
---|---|
Nutraceutical targeting of TLR4 signaling has potential for prevention of cancer cachexia.
Topics: 3-Hydroxybutyric Acid; Adipocytes; Biotin; Cachexia; Carnitine; Catechin; Coumaric Acids; Dietary Supplements; Fatty Acids, Omega-3; Glycine; Humans; Macrophages; Muscle, Skeletal; Neoplasms; Phycobilins; Phycocyanin; Signal Transduction; Tea; Toll-Like Receptor 4 | 2019 |
Nutraceutical inhibition of muscle proteolysis: a role of diallyl sulphide in the treatment of muscle wasting.
Topics: Allyl Compounds; Animals; Anorexia; Cachexia; Catechin; Cells, Cultured; Dietary Supplements; Genistein; Male; Muscle, Skeletal; Muscular Atrophy; Neoplasms; Rats; Rats, Wistar; Resveratrol; Stilbenes; Sulfides; Weight Loss | 2011 |
Epigallocatechin-3-gallate effectively attenuates skeletal muscle atrophy caused by cancer cachexia.
Topics: Animals; Anticarcinogenic Agents; Blotting, Western; Cachexia; Carcinoma, Lewis Lung; Catechin; Fluorescent Antibody Technique; Male; Mice; Mice, Inbred C57BL; Muscle Proteins; Muscle, Skeletal; Muscular Atrophy; NF-kappa B; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; SKP Cullin F-Box Protein Ligases; Tripartite Motif Proteins; Ubiquitin-Protein Ligases | 2011 |